Oxybutynin
اکسیبوتینین
🚻 Genito Urinary System And Sex HormonesUrinary antimuscarinic
Market / country: 🇺🇸 USA
Ditropan (US)
🧮 Dose calculator
Overactive bladder · Regimen source: FDA Oxybutynin · Dosage and Administration
- • Max 5 mg four times daily. Frail elderly: start 2.5 mg two or three times daily. FDA Oxybutynin · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Urinary or gastric retention, severe decreased GI motility, uncontrolled narrow-angle glaucoma (or at risk); hypersensitivity. FDA Oxybutynin · Contraindications
- ⛔ Not established under 5 years. FDA Oxybutynin · Pediatric Use
Formulations
- 2.5 mg tablet — tablet 🇺🇸 USA FDA Oxybutynin · How Supplied
- 5 mg tablet (scored) — tablet 🇺🇸 USA FDA Oxybutynin · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Oxybutynin · Pregnancy
“Reproduction studies using oxybutynin chloride in the hamster, rabbit, rat, and mouse have shown no definite evidence of impaired fertility or harm to the animal fetus.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Oxybutynin · Nursing Mothers
“Because many drugs are excreted in human milk, caution should be exercised when oxybutynin chloride is administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Oxybutynin · Pediatric Use
“The safety and efficacy of oxybutynin chloride administration have been demonstrated for pediatric patients 5 years of age and older (see DOSAGE AND ADMINISTRATION ).”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Oxybutynin · Geriatric Use
“… e elimination half-life from 2 to 3 hours to 5 hours. 2,3,4 In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA209025
- DailyMed (FDA label)FDA Oxybutynin
- MedlinePlus (NIH)OxybutyninOxybutynin Topical
- WHO ATC/DDDG04BD04
- Darooyab (Iran)Oxybutynin-Chloride
🇮🇷 Registered in Iran Darooyab · G-906/Oxybutynin-Chloride
Dosage forms with Iranian generic codes, per Darooyab.
- 00935 · OXYBUTYNIN CHLORIDE 5MG TAB · قرص اکسیبوتینین کلراید ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Oxybutynin · How SuppliedFDA Oxybutynin · Dosage and AdministrationFDA Oxybutynin · ContraindicationsFDA Oxybutynin · Pediatric UseFDA Oxybutynin · PregnancyFDA Oxybutynin · Nursing MothersFDA Oxybutynin · Geriatric UseFDA Oxybutynin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-906/Oxybutynin-Chloride
- Clinical review⚠ Unverified